The Mundipharma global network of independent associated companies seeks to identify and accelerate the development of meaningful medicines that add value for patients and healthcare providers around the globe. Founded in the US by two physicians in 1952 and still privately owned, the network is equivalent to a mid-sized pharmaceutical company, with a presence in over 120 countries.
As a network, we have a strong track record of building successful alliances to license, develop and market medicines that improve patients’ lives, while also providing attractive options to financially constrained healthcare systems. Consistent with our entrepreneurial heritage, we like to think we see what others don’t by challenging conventional wisdom and asking different and challenging questions.
We are global leaders in pain medicines, with a significant, and growing presence in our three other core therapeutic areas of respiratory, oncology and biosimilars.
For more information see www.mundipharma.com
Mundipharma International Limited is part of and provides support to the Mundipharma network.